US20040230300A1 - Accommodating positive and negative intraocular lens system - Google Patents

Accommodating positive and negative intraocular lens system Download PDF

Info

Publication number
US20040230300A1
US20040230300A1 US10/871,935 US87193504A US2004230300A1 US 20040230300 A1 US20040230300 A1 US 20040230300A1 US 87193504 A US87193504 A US 87193504A US 2004230300 A1 US2004230300 A1 US 2004230300A1
Authority
US
United States
Prior art keywords
lens
eye
negative
positive
intraocular lens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/871,935
Inventor
Mark Bandhauer
George Green
Donald Stenger
Michael Landreville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/871,935 priority Critical patent/US20040230300A1/en
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED MERGER (SEE DOCUMENT FOR DETAILS). Assignors: BAUSCH & LOMB SURGICAL, INC.
Publication of US20040230300A1 publication Critical patent/US20040230300A1/en
Assigned to CREDIT SUISSE reassignment CREDIT SUISSE SECURITY AGREEMENT Assignors: B & L DOMESTIC HOLDINGS CORP., B&L CRL INC., B&L CRL PARTNERS L.P., B&L FINANCIAL HOLDINGS CORP., B&L MINORITY DUTCH HOLDINGS LLC, B&L SPAF INC., B&L VPLEX HOLDINGS, INC., BAUSCH & LOMB CHINA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB INTERNATIONAL INC., BAUSCH & LOMB REALTY CORPORATION, BAUSCH & LOMB SOUTH ASIA, INC., BAUSCH & LOMB TECHNOLOGY CORPORATION, IOLAB CORPORATION, RHC HOLDINGS, INC., SIGHT SAVERS, INC., WILMINGTON MANAGEMENT CORP., WILMINGTON PARTNERS L.P., WP PRISM, INC.
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/02Artificial eyes from organic plastic material
    • B29D11/023Implants for natural eyes
    • B29D11/026Comprising more than one lens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1629Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing longitudinal position, i.e. along the visual axis when implanted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1635Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1648Multipart lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0053Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in optical properties

Definitions

  • the present invention relates to an intraocular lens (IOL) system and a method for making and using the same. More particularly, the present invention relates to an accommodating IOL system designed for multi-distance visual imaging in aphakic eyes where a diseased natural lens has been surgically removed, such as in the case of cataracts.
  • IOL intraocular lens
  • IOL implants have been used for many years in aphakic eyes as replacements for diseased natural crystalline lenses that have been surgically removed from the eyes.
  • Many different IOL designs have been developed over past years and proven successful for use in aphakic eyes.
  • Successful IOL designs to date primarily include an optic portion with supports therefor, called haptics, connected to and surrounding at least part of the optic portion.
  • the haptic portions of an IOL are designed to support the optic portion of the IOL in the lens capsule, anterior chamber or posterior chamber of an eye.
  • IOLs have been made from a variety of biocompatible materials, ranging from more rigid materials such as polymethylmethacrylate (PMMA) to softer, more flexible materials capable of being folded or compressed such as silicones, certain acrylics, and hydrogels.
  • PMMA polymethylmethacrylate
  • Haptic portions of the IOLs have been formed separately from the optic portion and later connected thereto through processes such as heat, physical staking and/or chemical bonding. Haptics have also been formed as an integral part of the optic portion in what is commonly referred to as “single-piece” IOLs.
  • Softer, more flexible IOLs have gained in popularity in more recent years due to their ability to be compressed, folded, rolled or otherwise deformed. Such softer IOLs may be deformed prior to insertion thereof through an incision in the cornea of an eye. Following insertion of the IOL in an eye, the IOL returns to its original pre-deformed shape due to the memory characteristics of the soft material. Softer, more flexible IOLs as just described may be implanted into an eye through an incision that is much smaller, i.e., 2.8 to 3.2 mm, than that necessary for more rigid IOLs, i.e., 4.8 to 6.0 mm.
  • a larger incision is necessary for more rigid IOLs because the lens must be inserted through an incision in the cornea slightly larger than the diameter of the inflexible IOL optic portion. Accordingly, more rigid IOLs have become less popular in the market since larger incisions have been found to be associated with an increased incidence of postoperative complications, such as induced astigmatism.
  • both softer and more rigid IOLs are subject to compressive forces exerted on the outer edges thereof from natural brain-induced contraction and relaxation of the ciliary muscle and increases and decreases in vitreous pressure. Compressive forces of this kind are useful in a phakic eye for focusing the eye at various distances.
  • Most commercially successful IOL designs for use in aphakic eyes have single focus optic portions that are fixed and focus the eye at only a certain fixed distance. Such fixed single focus IOLs require the wearing of glasses to change the focus of the eye.
  • a few fixed bifocal IOLs have been introduced to the commercial market but suffer from the disadvantage that each bifocal image represents only about forty percent of the available light thus lessening visual acuity.
  • An accommodating intraocular lens (IOL) system made in accordance with the present invention has a positive intraocular lens used in conjunction with a negative intraocular lens.
  • the positive intraocular lens has a “higher” diopter, preferably approximately +20 diopter or greater, such as but not limited to +20 to +60 diopter, positive optic portion with an outer peripheral edge and two or more but preferably two, three or four haptic elements for supporting the optic portion in a patient's eye.
  • the negative intraocular lens has a “lower” diopter, preferably approximately ⁇ 10 diopter or less, such as but not limited to ⁇ 10 to ⁇ 50 diopter, negative optic portion also having an outer peripheral edge and preferably the same, but optionally a different number of haptics from that of the positive optic portion.
  • Positive and negative intraocular lenses each having two haptic elements are balanced for stability within an eye to minimize decentration by having a haptic element integrally formed with or subsequently attached to two opposed edges of each of the two optic portions.
  • Positive and negative intraocular lenses each having three haptic elements are balanced to achieve stability and minimize decentration by having a set of two haptic elements integrally formed with or subsequently attached to one edge of each of the optic portions and a third haptic element integrally formed with or subsequently attached to an opposite edge of each of the optic portions.
  • Positive and negative lenses each having four haptic elements are balanced to achieve stability and minimize decentration by each optic portion having a set of two haptic elements integrally formed with or subsequently attached to one edge of the optic and a set of two haptic elements integrally formed with or subsequently attached to an opposite edge of the optic.
  • Each haptic element has an attachment portion that permanently connects the haptic element to the outer peripheral edge of an optic portion.
  • the haptic element is of a looped design
  • the haptic element has generally two attachment portions that permanently connect the looped haptic element to the outer peripheral edge of the optic portion.
  • a set of two looped haptic elements may have three attachment portions rather than four.
  • one of the three attachment portions is common to each of the two looped haptic elements in the set.
  • Each haptic element whether of a loop design or not includes a flexible central portion located between the attachment portion and a contact plate. The contact plate is designed to engage an inner surface of a patient's eye.
  • each haptic element is designed to have less resistance to bending in a plane generally parallel to the optical axis of an eye than in a plane generally perpendicular to the optical axis of an eye.
  • Another object of the present invention is to provide accommodating intraocular lens systems for use in aphakic eyes, which achieves axial displacement of the higher diopter optic portion with regard to the lower diopter optic portion along the optical axis of the eyes.
  • Another object of the present invention is to maximize accommodative effects of the intraocular lens system with even minimal optic axial displacement.
  • Another object of the present invention is to provide accommodating intraocular lens systems for use in aphakic eyes, which minimize damage to tissues in the interior of the eyes.
  • Still another object of the present invention is to provide accommodating intraocular lens systems, which are resistant to decentration within the eyes.
  • FIG. 1 is a schematic representation of the interior of a human eye
  • FIG. 2 is a plan view of an accommodating IOL system with each optic portion having three haptics made in accordance with the present invention
  • FIG. 3 is a side view of the IOL system of FIG. 2;
  • FIG. 4 is a cross sectional view of the IOL system of FIG. 2 taken along line 4 - 4 ;
  • FIG. 5 is a side view of the haptic elements of FIG. 3 with sharper edges;
  • FIG. 6 is a side view of the haptic elements of FIG. 3 with rounded edges;
  • FIG. 7 is a cross sectional view of the haptic elements of FIG. 5 with a stiffening element
  • FIG. 8 is a plan view of an accommodating IOL system with each optic portion having four haptics made in accordance with the present invention
  • FIG. 9 is a side view of the IOL system of FIG. 8;
  • FIG. 10 is a plan view of an accommodating IOL system with each optic portion having two haptics made in accordance with the present invention.
  • FIG. 11 is a side view of the IOL of FIG. 10.
  • FIG. 1 illustrates a simplified diagram of an eye 10 showing landmark structures relevant to the implantation of an intraocular lens of the present invention.
  • Eye 10 includes an optically clear cornea 12 and an iris 14 .
  • a natural crystalline lens 16 and a retina 18 are located behind the iris 14 of eye 10 .
  • Eye 10 also includes anterior chamber 20 located in front of iris 14 and a posterior chamber 22 located between iris 14 and natural lens 16 .
  • Accommodating IOL systems of the present invention are preferably implanted in lens capsule 24 after the removal of diseased natural lens 16 .
  • Eye 10 also includes an optical axis OA-OA that is an imaginary line that passes through the optical center 26 of anterior surface 28 and posterior surface 30 of natural lens 16 .
  • Optical axis OA-OA in the human eye 10 is generally perpendicular to a portion of cornea 12 , natural lens 16 and retina 18 .
  • IOL system 32 The IOL system of the present invention, as illustrated in FIGS. 2 through 11 but best illustrated in FIGS. 2, 8 and 10 , is identified generally by reference numeral 32 .
  • IOL system 32 comprises a positive lens 33 having a higher diopter optic portion 34 with an outer peripheral edge 36 and a negative lens 35 having a lower diopter optic portion 37 with an outer peripheral edge 39 .
  • IOL system 32 is designed for implantation preferably in lens capsule 24 of a patient's eye 10 .
  • positive lens 33 may be placed in lens capsule 24 and negative lens 35 may be manufactured as a standard anterior chamber intraocular lens to minimize tissue damage, such as that disclosed in U.S. Pat. No. 5,300,117, incorporated herein in its entirety by reference, and positioned within anterior chamber 20 .
  • positive lens 33 is preferably positioned anterior to negative lens 35 and anteriorly vaulted, i.e., vaulted toward iris 14 , and negative lens 35 positioned posterior to positive lens 33 and posteriorly vaulted, i.e., vaulted toward retina 18 .
  • haptic elements 40 and 43 are two or more but preferably two, three or four looped or non-looped haptic elements 40 and 43 respectively, each having an edge portion 42 and 45 respectively.
  • Haptic elements 40 and 43 are preferably integrally formed with and permanently connected to outer peripheral edges 36 and 39 of optic portions 34 and 37 by attachment portions 44 .
  • haptic elements 40 and 43 may be attached to optic portions 34 and 37 by staking, chemical polymerization or other methods known to those skilled in the art.
  • Each haptic element 40 and 43 also includes a broadened contact plate 38 and 41 respectively designed to preferably engage inner surfaces 50 in lens capsule 24 of eye 10 . Broadened contact plates 38 and 41 may be designed for direct contact as illustrated in FIGS.
  • Such designs may include, but are not limited to, contact plate 41 having a trough 70 and contact plate 38 having a ridge 72 to achieve preferably nonpermanent, but alternatively permanent, interlocking of positive lens 33 and negative lens 35 (FIG. 11) or an extended tab 74 on edge 45 of contact plate 41 to achieve preferably nonpermanent, but alternatively permanent, interlocking with edge 42 of contact plate 38 of positive lens 33 (FIG. 3).
  • contact plates 38 and 41 of positive lens 33 and negative lens 35 may be positioned so as to avoid direct contact upon placement within lens capsule 24 .
  • haptic elements 40 and 43 are designed so that when IOL system 32 is implanted in the lens capsule 24 of a patient's eye 10 and held in place through compressive forces exerted by inner surfaces 50 on contact plates 38 and 41 of haptic elements 40 and 43 respectively, haptic elements 40 and 43 flex so that contact plates 38 and 41 do not slide along surfaces 50 in eye 10 . Accordingly, haptic elements 40 and 43 are designed to flex in a plane generally perpendicular to that of optic portions 34 and 37 of IOL system 32 and generally parallel to that of optical axis OA-OA of eye 10 . Haptic elements 40 and 43 flex to achieve displacement of lens 33 with respect to lens 35 .
  • lens 35 When IOL system 32 is implanted within lens capsule 24 , lens 35 may be fixed whereby only lens 33 is axially displaced to achieve multi-distance visual imaging. However, it is preferable to maximize accommodative effects through opposed axial displacement of both lenses 33 and 35 .
  • IOL system 32 achieves maximum accommodative effect to allow an eye to achieve multi-distance visual imaging without the aid of eyeglasses.
  • the flexibility characteristic and vaulting of haptic elements 40 and 43 enables axial displacement of optic portions 34 and 37 in opposite directions along optical axis OA-OA of eye 10 .
  • the accommodative effects of the IOL system 32 are even greater.
  • the IOL system 32 of the present invention with its maximized accommodative effects through the axial displacement of optic portion 34 with respect to optic portion 37 enables an eye to achieve multi-distance visual imaging when compressive forces are applied to eye 10 without the use of eyeglasses.
  • IOL system 32 has haptic elements 40 and 43 formed with flexible central portions 62 adjacent to attachment portions 44 permanently connected to outer peripheral edges 36 and 39 of optic portions 34 and 37 respectively.
  • Flexible central portions 62 are essential in imparting the necessary flexibility to the IOLs of the present invention.
  • Flexible central portions 62 have a dimension in plane 46 - 46 generally parallel to optical axis OA-OA, as depicted in FIGS. 3, 9 and 11 , less than or equal to but most preferably less than the same in plane 48 - 48 generally perpendicular to optical axis OA-OA as depicted in FIG. 2, 8 and 10 .
  • Contact plates 38 and 41 are relatively flat with either rounded edges 52 as depicted in FIG. 6 to provide a smoother fit with inner surfaces 50 , or more defined, sharper edges 54 as depicted in FIG. 7 to provide a barrier to prevent cellular migration and growth upon implantation in lens capsule 24 .
  • the subject IOL system 32 is preferably manufactured to have optic portions 34 and 37 approximately 4 . 5 to 9 . 0 mm, but preferably approximately 5.0 to 6.0 mm and most preferably approximately 5.5 to 6.0 mm in diameter and approximately 0.15 mm to 1.0 mm, but preferably approximately 0.6 to 0.8 mm and most preferably approximately 0.7 mm in thickness at peripheral edge 36 .
  • Haptic elements 40 and 43 extend from the optic portions 34 and 37 respectively of IOL system 32 in a generally rounded or oval configuration and will increase or decrease in overall length depending upon the size of IOL system 32 desired and the diameter of optic portions 34 and 37 . As the diameter of optic portions 34 and/or 37 increases, the overall length of haptic elements 40 and/or 43 may be decreased.
  • haptic elements 40 and/or 43 may be increased. However, as customary, the overall length of the haptic elements 40 and 43 are varied to achieve desired IOL system 32 sizes rather than varying the sizes of optic portions 34 and/or 37 .
  • looped haptic elements 40 and 43 as illustrated in FIGS. 2, 8 and 10 are formed to be approximately 2.6 to 6.0 mm, but preferably approximately 3.4 to 5.0 mm and most preferably approximately 4.2 mm in length measuring from a point of equal distance between common attachment portions 44 on peripheral edges 36 and 39 , to the center of contact plates 38 and 41 respectively.
  • Looped haptic elements 40 and 43 preferably have a generally rounded or oval configuration as illustrated in FIGS. 10 and 11 to allow axial deflection under compressive forces.
  • Non-looped haptic elements 40 and 43 as illustrated in FIGS. 8 and 9 are formed to be approximately 2.6 to 6.0 mm, but preferably approximately 3.4 to 5.0 mm and most preferably approximately 4.2 mm in length measuring from the middle of attachment portion 44 on peripheral edges 36 and 39 , to the center of contact plates 38 and 41 respectively.
  • Non-looped haptic elements 40 and 43 preferably have a generally rounded or oval configuration as illustrated in FIGS. 8 and 9 to provide a suitable stable fit within lens capsule 24 while allowing axial deflection under compressive forces.
  • the generally rounded or oval shape of looped and non-looped haptic elements 40 and 43 i.e., the beam curve shape, relative to the width to thickness ratio, i.e., the aspect ratio, of haptic elements 40 and 43 as described herein is critical to achieve suitable function.
  • Flexible central portion 62 of haptic elements 40 and 43 is approximately 0.5 to 2.5 mm, but preferably approximately 1.0 to 2.0 mm and most preferably approximately 1.6 mm in length; approximately 0.2 to 1.0 mm, but preferably approximately 0.3 to 0.7 mm and most preferably approximately 0.46 mm in width in plane 48 - 48 and approximately 0.2 to 0.7 mm, but preferably approximately 0.3 to 0.6 and most preferably approximately 0.43 mm in thickness in plane 46 - 46 .
  • Contact plates 38 and 41 are approximately 0.8 to 2.5 mm, but preferably approximately 1.0 to 2.2 mm and most preferably approximately 1.8 mm in length, approximately 0.05 to 0.5 mm, but preferably approximately 0.1 to 0.4 mm and most preferably approximately 0.3 mm in thickness and approximately 0.6 to 1.5 mm, but preferably approximately 0.8 to 1.2 mm and most preferably approximately 1.0 mm in width.
  • looped and non-looped haptic elements 40 and 43 are relatively thick in plane 48 - 48 at contact plates 38 and 41 through to attachment portions 44 and optic portions 34 and 37 , with flexible central portions 62 preferably exhibiting a thinner dimension in plane 46 - 46 than that of the width in plane 48 - 48 .
  • Looped haptic elements 40 and 43 of the subject IOL system 32 tend to resist deflection into closer proximity with outer peripheral edges 36 and 39 respectively when a compression force is exerted against contact plates 38 and 41 to maximize axial displacement along optical axis OA-OA.
  • accommodating IOL system 32 is used as a refractive lens, stable, reliable multi-distance visual imaging is provided.
  • haptic elements 40 and 43 of IOL system 32 may likewise be achieved or enhanced by incorporating a stiffening element 60 , in the shape of a wide, very thin ribbon, in one or more haptic elements 40 and 43 , as illustrated in FIG. 8.
  • Stiffening element 60 may be positioned in haptic elements 40 and 43 so that wide or broad flat face 62 is oriented in a plane parallel to that of plane 48 - 48 so as to be thin axially in a plane parallel to that of plane 46 - 46 .
  • Stiffening element 60 functions in a manner similar to that of an I-beam in construction to maximize axial displacement along optical axis OA-OA when compressive force is applied to contact plates 38 and 41 .
  • Stiffening element 60 is formed of a less flexible material than that of IOL system 32 .
  • Suitable materials for stiffening element 60 include but are not limited to polymethyl methacrylate, polyimides, polyolefins, high-density polyethylenes, polyesters, nylons, metals or any biocompatible material with suitable stiffening characteristics.
  • Stiffening element 60 may be fabricated using one or more layers of a mesh, screen, webbing and/or sheet to impart the desired flexibility characteristics described herein. Stiffening element 60 may be used in conjunction with haptic elements 40 and 43 described above in cases where a thinner haptic design is desired while still achieving the desired stability and flexibility characteristics.
  • Suitable materials for the production of the subject IOL system 32 include but are not limited to foldable or compressible materials, such as silicone polymers, hydrocarbon and fluorocarbon polymers, hydrogels, soft acrylic polymers, polyesters, polyamides, polyurethane, silicone polymers with hydrophilic monomer units, fluorine-containing polysiloxane elastomers and combinations thereof.
  • the preferred material for the production of IOL system 32 of the present invention is a hydrogel made from 2-hydroxyethyl methacrylate (HEMA) and 6-hydroxyhexyl methacrylate (HOHEXMA), i.e., poly(HEMA-co-HOHEXMA).
  • Poly(HEMA-co-HOHEXMA) is the preferred material for the manufacture of IOL 32 due to its equilibrium water content of approximately 18 percent by weight, and high refractive index of approximately 1.474, which is greater than that of the aqueous humor of the eye, i.e., 1.336.
  • a high refractive index is a desirable feature in the production of IOLs to impart high optical power with a minimum of optic thickness. By using a material with a high refractive index, visual acuity deficiencies may be corrected using a thinner IOL.
  • Poly(HEMA-co-HOHEXMA) is a desirable material in the production of IOL system 32 due to its mechanical strength, which is suitable to withstand considerable physical manipulation.
  • Poly(HEMA-co-HOHEXMA) also has desirable memory properties suitable for IOL use. IOLs manufactured from a material possessing good memory properties such as those of poly(HEMA-co-HOHEXMA) unfold in a more controlled manner in an eye, rather than explosively, to its predetermined shape.
  • the unique design of the subject IOL system 32 with haptic elements 40 and 43 manufactured from a material having good memory properties also provides improved control of haptic unfolding upon insertion thereof in eye 10 . Explosive unfolding of IOLs is undesirable due to potential damage to delicate tissues within the eye.
  • Poly(HEMA-co-HOHEXMA) also has dimensional stability in the eye, which is desirable.
  • the teachings of the present invention are preferably applied to soft or foldable IOLs formed of a foldable or compressible material, the same may also be applied to harder, less flexible lenses formed of a relatively rigid material such as polymethylmethacrylate (PMMA) having flexible haptics formed either of the same or a different material.
  • PMMA polymethylmethacrylate
  • Positive optic portion 34 of IOL system 32 can be a positive powered lens of approximately + 20 diopter or greater but preferably approximately +20 to +60 diopter and negative optic portion 37 of IOL system 32 can be a negative powered lens of approximately - 10 diopter or less but preferably ⁇ 10 to ⁇ 50 diopter.
  • Optic portions 34 and 37 may be a combination of biconvex, plano-convex, plano-concave, biconcave, concave-convex (meniscus) or a diffractive-type lens element of any shape, depending upon the power required to achieve the appropriate accommodative effects for multi-distance visual imaging and to achieve appropriate central and peripheral thickness for efficient handling and fit within the eye 10 .
  • positive lens 33 is convex-plano and negative lens 35 is plano-convex so the piano surface of positive lens 33 is in close proximity to the piano surface of negative lens 35 , but most preferably, positive lens 33 is convex-plano and negative lens 35 is concave-plano so the piano surface of positive lens 33 is in close proximity to the concave surface of negative lens 35 .
  • Optic portions 34 and 37 of the subject IOL system 32 may optionally be formed with a glare reduction zone 56 of approximately 0.25 to 2.00 mm but more preferably approximately 0.3 to 0.6 mm and most preferably 0.5 mm in width adjacent outer peripheral edge 36 and 39 for reducing glare when outer peripheral edge 36 and 39 of IOL system 32 is struck by light entering eye 10 during high light or at other times when pupil 58 is dilated.
  • Glare reduction zone 56 is typically fabricated of the same material as optic portions 34 and 37 , but may be opaque, colored or patterned in a conventional manner to block or diffuse light in plane with optical axis OA-OA.
  • Subject IOL system 32 may or may not be of a unitary design and may be molded or most preferably manufactured by first producing disks from a material of choice as described in U.S. Pat. Nos. 5,217,491 and 5,326,506, each incorporated herein in its entirety by reference. If manufactured from disks, positive and negative lenses 33 and 35 respectively, are machined from material disks in a conventional manner. Once machined or molded, positive and negative lenses 33 and 35 may be polished, cleaned, sterilized and packaged by a conventional method known to those skilled in the art.
  • Subject IOL system 32 is used in eye 10 by creating an incision in cornea 12 and capsule 24 , removing natural lens 16 , inserting negative lens 35 and positive lens 33 as a unitary device or individually into capsule 24 and closing the incision.
  • lenses 35 and 33 are inserted into capsule 24 individually to allow for easier lens folding and smaller incision size.
  • the subject IOL system 32 may be used in eye 10 by creating an incision in cornea 12 and capsule 24 , removing natural lens 16 , inserting positive lens 33 into capsule 24 , inserting negative lens 35 into anterior chamber 20 and closing the incision.
  • IOL system 32 of the present invention provides for an accommodating lens suitable for use in an aphakic eye 10 .
  • IOL system 32 comprises two intraocular lens each having haptic elements 40 and 43 with flexibility characteristics that facilitate opposed axial displacement of optic portions 34 and 37 along optical axis OA-OA of eye 10 thereby enabling an eye to achieve multi-distance visual imaging without the aid of eyeglasses.

Abstract

An accommodating intraocular lens system including a higher diopter positive intraocular lens and a lower diopter negative intraocular lens. The positive intraocular lens includes a positive optic portion having an outer peripheral edge and two or more haptic elements. The negative intraocular lens includes a negative optic portion having an outer peripheral edge and two or more haptic elements. Each haptic element is formed to have specific flexibility characteristics so as to be less resistant to bending in a plane generally parallel to an eye's optical axis than in a plane generally perpendicular to the eye's optical axis. The accommodating intraocular lens system is so designed with specific flexibility characteristics to facilitate axial displacement of the positive optic portion with respect to the negative optic portion along the eye's optical axis under a compression force. Through the axial displacement of the positive optic portion with respect to the negative optic portion, accommodative effects are maximized to achieve multi-distance visual imaging.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. Ser. No. 09/434,635 filed Nov. 5, 1999.[0001]
  • FIELD OF THE INVENTION
  • The present invention relates to an intraocular lens (IOL) system and a method for making and using the same. More particularly, the present invention relates to an accommodating IOL system designed for multi-distance visual imaging in aphakic eyes where a diseased natural lens has been surgically removed, such as in the case of cataracts. [0002]
  • BACKGROUND OF THE INVENTION
  • IOL implants have been used for many years in aphakic eyes as replacements for diseased natural crystalline lenses that have been surgically removed from the eyes. Many different IOL designs have been developed over past years and proven successful for use in aphakic eyes. Successful IOL designs to date primarily include an optic portion with supports therefor, called haptics, connected to and surrounding at least part of the optic portion. The haptic portions of an IOL are designed to support the optic portion of the IOL in the lens capsule, anterior chamber or posterior chamber of an eye. [0003]
  • Commercially successful IOLs have been made from a variety of biocompatible materials, ranging from more rigid materials such as polymethylmethacrylate (PMMA) to softer, more flexible materials capable of being folded or compressed such as silicones, certain acrylics, and hydrogels. Haptic portions of the IOLs have been formed separately from the optic portion and later connected thereto through processes such as heat, physical staking and/or chemical bonding. Haptics have also been formed as an integral part of the optic portion in what is commonly referred to as “single-piece” IOLs. [0004]
  • Softer, more flexible IOLs have gained in popularity in more recent years due to their ability to be compressed, folded, rolled or otherwise deformed. Such softer IOLs may be deformed prior to insertion thereof through an incision in the cornea of an eye. Following insertion of the IOL in an eye, the IOL returns to its original pre-deformed shape due to the memory characteristics of the soft material. Softer, more flexible IOLs as just described may be implanted into an eye through an incision that is much smaller, i.e., 2.8 to 3.2 mm, than that necessary for more rigid IOLs, i.e., 4.8 to 6.0 mm. A larger incision is necessary for more rigid IOLs because the lens must be inserted through an incision in the cornea slightly larger than the diameter of the inflexible IOL optic portion. Accordingly, more rigid IOLs have become less popular in the market since larger incisions have been found to be associated with an increased incidence of postoperative complications, such as induced astigmatism. [0005]
  • After IOL implantation, both softer and more rigid IOLs are subject to compressive forces exerted on the outer edges thereof from natural brain-induced contraction and relaxation of the ciliary muscle and increases and decreases in vitreous pressure. Compressive forces of this kind are useful in a phakic eye for focusing the eye at various distances. Most commercially successful IOL designs for use in aphakic eyes have single focus optic portions that are fixed and focus the eye at only a certain fixed distance. Such fixed single focus IOLs require the wearing of glasses to change the focus of the eye. A few fixed bifocal IOLs have been introduced to the commercial market but suffer from the disadvantage that each bifocal image represents only about forty percent of the available light thus lessening visual acuity. [0006]
  • Because of the noted shortcomings of current IOL designs, there is a need for accommodating IOLs designed to provide improved visual imaging at various distances in aphakic eyes without the aid of eyeglasses. [0007]
  • SUMMARY OF THE INVENTION
  • An accommodating intraocular lens (IOL) system made in accordance with the present invention has a positive intraocular lens used in conjunction with a negative intraocular lens. The positive intraocular lens has a “higher” diopter, preferably approximately +20 diopter or greater, such as but not limited to +20 to +60 diopter, positive optic portion with an outer peripheral edge and two or more but preferably two, three or four haptic elements for supporting the optic portion in a patient's eye. The negative intraocular lens has a “lower” diopter, preferably approximately −10 diopter or less, such as but not limited to −10 to −50 diopter, negative optic portion also having an outer peripheral edge and preferably the same, but optionally a different number of haptics from that of the positive optic portion. Positive and negative intraocular lenses each having two haptic elements are balanced for stability within an eye to minimize decentration by having a haptic element integrally formed with or subsequently attached to two opposed edges of each of the two optic portions. Positive and negative intraocular lenses each having three haptic elements are balanced to achieve stability and minimize decentration by having a set of two haptic elements integrally formed with or subsequently attached to one edge of each of the optic portions and a third haptic element integrally formed with or subsequently attached to an opposite edge of each of the optic portions. Positive and negative lenses each having four haptic elements are balanced to achieve stability and minimize decentration by each optic portion having a set of two haptic elements integrally formed with or subsequently attached to one edge of the optic and a set of two haptic elements integrally formed with or subsequently attached to an opposite edge of the optic. Each haptic element has an attachment portion that permanently connects the haptic element to the outer peripheral edge of an optic portion. If the haptic element is of a looped design, the haptic element has generally two attachment portions that permanently connect the looped haptic element to the outer peripheral edge of the optic portion. In the case of lenses having three or four looped haptic elements, a set of two looped haptic elements may have three attachment portions rather than four. In such a case, one of the three attachment portions is common to each of the two looped haptic elements in the set. Each haptic element whether of a loop design or not includes a flexible central portion located between the attachment portion and a contact plate. The contact plate is designed to engage an inner surface of a patient's eye. The flexible central portions that extend between the contact plates and the attachment portions allow the optic portions of both the positive and negative lenses to move or to adjust to pressures exerted on the positive and negative lenses within the eye. Additionally, within these flexible central portions, each haptic element is designed to have less resistance to bending in a plane generally parallel to the optical axis of an eye than in a plane generally perpendicular to the optical axis of an eye. By providing haptic elements with this type of flexibility characteristic, the present accommodating IOL system achieves axial displacement of the positive optic portion with regard to the negative optic portion along the optical axis of the eye when compressive forces are exerted against the accommodating IOL system. Also, by combining a higher diopter positive optic portion with that of a lower diopter negative optic portion, an additive effect is achieved whereby even slight movement or axial displacement of the higher diopter positive optic portion with regard to the lower diopter negative optic portion achieves a significantly large increase in accommodative effect and improved multi-distance visual imaging without the aid of eyeglasses. [0008]
  • Accordingly, it is an object of the present invention to provide accommodating intraocular lens systems for use in aphakic eyes. [0009]
  • Another object of the present invention is to provide accommodating intraocular lens systems for use in aphakic eyes, which achieves axial displacement of the higher diopter optic portion with regard to the lower diopter optic portion along the optical axis of the eyes. [0010]
  • Another object of the present invention is to maximize accommodative effects of the intraocular lens system with even minimal optic axial displacement. [0011]
  • Another object of the present invention is to provide accommodating intraocular lens systems for use in aphakic eyes, which minimize damage to tissues in the interior of the eyes. [0012]
  • Still another object of the present invention is to provide accommodating intraocular lens systems, which are resistant to decentration within the eyes. [0013]
  • These and other objectives and advantages of the present invention, some of which are specifically described and others that are not, will become apparent from the detailed description, drawings and claims that follow, wherein like features are designated by like numerals.[0014]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic representation of the interior of a human eye; [0015]
  • FIG. 2 is a plan view of an accommodating IOL system with each optic portion having three haptics made in accordance with the present invention; [0016]
  • FIG. 3 is a side view of the IOL system of FIG. 2; [0017]
  • FIG. 4 is a cross sectional view of the IOL system of FIG. 2 taken along line [0018] 4-4;
  • FIG. 5 is a side view of the haptic elements of FIG. 3 with sharper edges; [0019]
  • FIG. 6 is a side view of the haptic elements of FIG. 3 with rounded edges; [0020]
  • FIG. 7 is a cross sectional view of the haptic elements of FIG. 5 with a stiffening element; [0021]
  • FIG. 8 is a plan view of an accommodating IOL system with each optic portion having four haptics made in accordance with the present invention; [0022]
  • FIG. 9 is a side view of the IOL system of FIG. 8; [0023]
  • FIG. 10 is a plan view of an accommodating IOL system with each optic portion having two haptics made in accordance with the present invention; and [0024]
  • FIG. 11 is a side view of the IOL of FIG. 10. [0025]
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 illustrates a simplified diagram of an [0026] eye 10 showing landmark structures relevant to the implantation of an intraocular lens of the present invention. Eye 10 includes an optically clear cornea 12 and an iris 14. A natural crystalline lens 16 and a retina 18 are located behind the iris 14 of eye 10. Eye 10 also includes anterior chamber 20 located in front of iris 14 and a posterior chamber 22 located between iris 14 and natural lens 16. Accommodating IOL systems of the present invention are preferably implanted in lens capsule 24 after the removal of diseased natural lens 16. Eye 10 also includes an optical axis OA-OA that is an imaginary line that passes through the optical center 26 of anterior surface 28 and posterior surface 30 of natural lens 16. Optical axis OA-OA in the human eye 10 is generally perpendicular to a portion of cornea 12, natural lens 16 and retina 18.
  • The IOL system of the present invention, as illustrated in FIGS. 2 through 11 but best illustrated in FIGS. 2, 8 and [0027] 10, is identified generally by reference numeral 32. IOL system 32 comprises a positive lens 33 having a higher diopter optic portion 34 with an outer peripheral edge 36 and a negative lens 35 having a lower diopter optic portion 37 with an outer peripheral edge 39. IOL system 32 is designed for implantation preferably in lens capsule 24 of a patient's eye 10. Alternatively, positive lens 33 may be placed in lens capsule 24 and negative lens 35 may be manufactured as a standard anterior chamber intraocular lens to minimize tissue damage, such as that disclosed in U.S. Pat. No. 5,300,117, incorporated herein in its entirety by reference, and positioned within anterior chamber 20. When IOL system 32 is positioned within lens capsule 24 of eye 10, positive lens 33 is preferably positioned anterior to negative lens 35 and anteriorly vaulted, i.e., vaulted toward iris 14, and negative lens 35 positioned posterior to positive lens 33 and posteriorly vaulted, i.e., vaulted toward retina 18. A vault of approximately 1.0 to 2.0 mm measuring from the plane of outer peripheral edges 36 and 39 of optic portions 34 and 37 respectively to the plane of haptic contact plates 38 and 41 respectively, described in detail below, is generally suitable. Preferably integrally formed on peripheral edges 36 and 39 of optic portions 34 and 37 are two or more but preferably two, three or four looped or non-looped haptic elements 40 and 43 respectively, each having an edge portion 42 and 45 respectively. Haptic elements 40 and 43 are preferably integrally formed with and permanently connected to outer peripheral edges 36 and 39 of optic portions 34 and 37 by attachment portions 44. Alternatively however, haptic elements 40 and 43 may be attached to optic portions 34 and 37 by staking, chemical polymerization or other methods known to those skilled in the art. Each haptic element 40 and 43 also includes a broadened contact plate 38 and 41 respectively designed to preferably engage inner surfaces 50 in lens capsule 24 of eye 10. Broadened contact plates 38 and 41 may be designed for direct contact as illustrated in FIGS. 3 and 11. Such designs may include, but are not limited to, contact plate 41 having a trough 70 and contact plate 38 having a ridge 72 to achieve preferably nonpermanent, but alternatively permanent, interlocking of positive lens 33 and negative lens 35 (FIG. 11) or an extended tab 74 on edge 45 of contact plate 41 to achieve preferably nonpermanent, but alternatively permanent, interlocking with edge 42 of contact plate 38 of positive lens 33 (FIG. 3). As another alternative, best illustrated in FIG. 8, contact plates 38 and 41 of positive lens 33 and negative lens 35 may be positioned so as to avoid direct contact upon placement within lens capsule 24.
  • In accordance with the present invention, [0028] haptic elements 40 and 43 are designed so that when IOL system 32 is implanted in the lens capsule 24 of a patient's eye 10 and held in place through compressive forces exerted by inner surfaces 50 on contact plates 38 and 41 of haptic elements 40 and 43 respectively, haptic elements 40 and 43 flex so that contact plates 38 and 41 do not slide along surfaces 50 in eye 10. Accordingly, haptic elements 40 and 43 are designed to flex in a plane generally perpendicular to that of optic portions 34 and 37 of IOL system 32 and generally parallel to that of optical axis OA-OA of eye 10. Haptic elements 40 and 43 flex to achieve displacement of lens 33 with respect to lens 35. When IOL system 32 is implanted within lens capsule 24, lens 35 may be fixed whereby only lens 33 is axially displaced to achieve multi-distance visual imaging. However, it is preferable to maximize accommodative effects through opposed axial displacement of both lenses 33 and 35. By using a higher diopter lens 33 and designing this type of flexibility characteristic into haptic elements 40 and 43, IOL system 32 achieves maximum accommodative effect to allow an eye to achieve multi-distance visual imaging without the aid of eyeglasses. The flexibility characteristic and vaulting of haptic elements 40 and 43 enables axial displacement of optic portions 34 and 37 in opposite directions along optical axis OA-OA of eye 10. Compressive forces of differing magnitudes within the range of approximately 0.1 to 5 mN exerted against contact plates 38 and 41 of haptic elements 40 and 43 to effect approximately an overall 1.0 mm in diameter compression of IOL system 32, such as that caused by natural brain-induced forces within eye 10, results in approximately 1.0 mm to 3.0 mm combined opposed axial displacement of optic portions 34 and 37 along optical axis OA-OA in an eye 10. By combining a higher diopter positive optic portion with that of a lower diopter negative optic portion, an additive effect is achieved whereby even slight movement or axial displacement of the higher diopter positive optic portion with regard to the lower diopter negative optic portion results in a disproportionately large increase in accommodative effect and improved multi-distance visual imaging without the aid of eyeglasses. For example, if one were to use a +50 diopter positive intraocular lens in conjunction with a −30 diopter negative intraocular lens for a combined +20 diopter effect, one achieves at least double the accommodative effect achieved using a single +20 diopter positive intraocular lens. By adding axial displacement of the higher diopter positive lens with respect to the lower diopter negative lens, the accommodative effects of the IOL system 32 are even greater. The IOL system 32 of the present invention with its maximized accommodative effects through the axial displacement of optic portion 34 with respect to optic portion 37 enables an eye to achieve multi-distance visual imaging when compressive forces are applied to eye 10 without the use of eyeglasses.
  • The flexibility characteristic of [0029] haptic elements 40 and 43 of IOL system 32 as described above is achieved through the unique design thereof. As best illustrated in FIG. 2, IOL system 32 has haptic elements 40 and 43 formed with flexible central portions 62 adjacent to attachment portions 44 permanently connected to outer peripheral edges 36 and 39 of optic portions 34 and 37 respectively. Flexible central portions 62 are essential in imparting the necessary flexibility to the IOLs of the present invention. Flexible central portions 62 have a dimension in plane 46-46 generally parallel to optical axis OA-OA, as depicted in FIGS. 3, 9 and 11, less than or equal to but most preferably less than the same in plane 48-48 generally perpendicular to optical axis OA-OA as depicted in FIG. 2, 8 and 10. Contact plates 38 and 41 are relatively flat with either rounded edges 52 as depicted in FIG. 6 to provide a smoother fit with inner surfaces 50, or more defined, sharper edges 54 as depicted in FIG. 7 to provide a barrier to prevent cellular migration and growth upon implantation in lens capsule 24.
  • The [0030] subject IOL system 32 is preferably manufactured to have optic portions 34 and 37 approximately 4.5 to 9.0 mm, but preferably approximately 5.0 to 6.0 mm and most preferably approximately 5.5 to 6.0 mm in diameter and approximately 0.15 mm to 1.0 mm, but preferably approximately 0.6 to 0.8 mm and most preferably approximately 0.7 mm in thickness at peripheral edge 36. Haptic elements 40 and 43 extend from the optic portions 34 and 37 respectively of IOL system 32 in a generally rounded or oval configuration and will increase or decrease in overall length depending upon the size of IOL system 32 desired and the diameter of optic portions 34 and 37. As the diameter of optic portions 34 and/or 37 increases, the overall length of haptic elements 40 and/or 43 may be decreased. Likewise, as the diameter of optic portions 34 and/or 37 decreases, the overall length of haptic elements 40 and/or 43 may be increased. However, as customary, the overall length of the haptic elements 40 and 43 are varied to achieve desired IOL system 32 sizes rather than varying the sizes of optic portions 34 and/or 37. In general, looped haptic elements 40 and 43 as illustrated in FIGS. 2, 8 and 10 are formed to be approximately 2.6 to 6.0 mm, but preferably approximately 3.4 to 5.0 mm and most preferably approximately 4.2 mm in length measuring from a point of equal distance between common attachment portions 44 on peripheral edges 36 and 39, to the center of contact plates 38 and 41 respectively. Looped haptic elements 40 and 43 preferably have a generally rounded or oval configuration as illustrated in FIGS. 10 and 11 to allow axial deflection under compressive forces. Non-looped haptic elements 40 and 43 as illustrated in FIGS. 8 and 9 are formed to be approximately 2.6 to 6.0 mm, but preferably approximately 3.4 to 5.0 mm and most preferably approximately 4.2 mm in length measuring from the middle of attachment portion 44 on peripheral edges 36 and 39, to the center of contact plates 38 and 41 respectively. Non-looped haptic elements 40 and 43 preferably have a generally rounded or oval configuration as illustrated in FIGS. 8 and 9 to provide a suitable stable fit within lens capsule 24 while allowing axial deflection under compressive forces. For purposes of the present invention, the generally rounded or oval shape of looped and non-looped haptic elements 40 and 43, i.e., the beam curve shape, relative to the width to thickness ratio, i.e., the aspect ratio, of haptic elements 40 and 43 as described herein is critical to achieve suitable function. Flexible central portion 62 of haptic elements 40 and 43 is approximately 0.5 to 2.5 mm, but preferably approximately 1.0 to 2.0 mm and most preferably approximately 1.6 mm in length; approximately 0.2 to 1.0 mm, but preferably approximately 0.3 to 0.7 mm and most preferably approximately 0.46 mm in width in plane 48-48 and approximately 0.2 to 0.7 mm, but preferably approximately 0.3 to 0.6 and most preferably approximately 0.43 mm in thickness in plane 46-46. Contact plates 38 and 41 are approximately 0.8 to 2.5 mm, but preferably approximately 1.0 to 2.2 mm and most preferably approximately 1.8 mm in length, approximately 0.05 to 0.5 mm, but preferably approximately 0.1 to 0.4 mm and most preferably approximately 0.3 mm in thickness and approximately 0.6 to 1.5 mm, but preferably approximately 0.8 to 1.2 mm and most preferably approximately 1.0 mm in width.
  • As provided through the dimensions of [0031] IOL system 32 above, looped and non-looped haptic elements 40 and 43 are relatively thick in plane 48-48 at contact plates 38 and 41 through to attachment portions 44 and optic portions 34 and 37, with flexible central portions 62 preferably exhibiting a thinner dimension in plane 46-46 than that of the width in plane 48-48. Looped haptic elements 40 and 43 of the subject IOL system 32 tend to resist deflection into closer proximity with outer peripheral edges 36 and 39 respectively when a compression force is exerted against contact plates 38 and 41 to maximize axial displacement along optical axis OA-OA. When accommodating IOL system 32 is used as a refractive lens, stable, reliable multi-distance visual imaging is provided.
  • The desired flexibility characteristic of [0032] haptic elements 40 and 43 of IOL system 32 may likewise be achieved or enhanced by incorporating a stiffening element 60, in the shape of a wide, very thin ribbon, in one or more haptic elements 40 and 43, as illustrated in FIG. 8. Stiffening element 60 may be positioned in haptic elements 40 and 43 so that wide or broad flat face 62 is oriented in a plane parallel to that of plane 48-48 so as to be thin axially in a plane parallel to that of plane 46-46. Stiffening element 60 functions in a manner similar to that of an I-beam in construction to maximize axial displacement along optical axis OA-OA when compressive force is applied to contact plates 38 and 41.
  • Stiffening [0033] element 60 is formed of a less flexible material than that of IOL system 32. Suitable materials for stiffening element 60 include but are not limited to polymethyl methacrylate, polyimides, polyolefins, high-density polyethylenes, polyesters, nylons, metals or any biocompatible material with suitable stiffening characteristics. Stiffening element 60 may be fabricated using one or more layers of a mesh, screen, webbing and/or sheet to impart the desired flexibility characteristics described herein. Stiffening element 60 may be used in conjunction with haptic elements 40 and 43 described above in cases where a thinner haptic design is desired while still achieving the desired stability and flexibility characteristics.
  • Suitable materials for the production of the [0034] subject IOL system 32 include but are not limited to foldable or compressible materials, such as silicone polymers, hydrocarbon and fluorocarbon polymers, hydrogels, soft acrylic polymers, polyesters, polyamides, polyurethane, silicone polymers with hydrophilic monomer units, fluorine-containing polysiloxane elastomers and combinations thereof. The preferred material for the production of IOL system 32 of the present invention is a hydrogel made from 2-hydroxyethyl methacrylate (HEMA) and 6-hydroxyhexyl methacrylate (HOHEXMA), i.e., poly(HEMA-co-HOHEXMA). Poly(HEMA-co-HOHEXMA) is the preferred material for the manufacture of IOL 32 due to its equilibrium water content of approximately 18 percent by weight, and high refractive index of approximately 1.474, which is greater than that of the aqueous humor of the eye, i.e., 1.336. A high refractive index is a desirable feature in the production of IOLs to impart high optical power with a minimum of optic thickness. By using a material with a high refractive index, visual acuity deficiencies may be corrected using a thinner IOL. Poly(HEMA-co-HOHEXMA) is a desirable material in the production of IOL system 32 due to its mechanical strength, which is suitable to withstand considerable physical manipulation. Poly(HEMA-co-HOHEXMA) also has desirable memory properties suitable for IOL use. IOLs manufactured from a material possessing good memory properties such as those of poly(HEMA-co-HOHEXMA) unfold in a more controlled manner in an eye, rather than explosively, to its predetermined shape. The unique design of the subject IOL system 32 with haptic elements 40 and 43 manufactured from a material having good memory properties also provides improved control of haptic unfolding upon insertion thereof in eye 10. Explosive unfolding of IOLs is undesirable due to potential damage to delicate tissues within the eye. Poly(HEMA-co-HOHEXMA) also has dimensional stability in the eye, which is desirable.
  • Although the teachings of the present invention are preferably applied to soft or foldable IOLs formed of a foldable or compressible material, the same may also be applied to harder, less flexible lenses formed of a relatively rigid material such as polymethylmethacrylate (PMMA) having flexible haptics formed either of the same or a different material. [0035]
  • [0036] Positive optic portion 34 of IOL system 32 can be a positive powered lens of approximately +20 diopter or greater but preferably approximately +20 to +60 diopter and negative optic portion 37 of IOL system 32 can be a negative powered lens of approximately -10 diopter or less but preferably −10 to −50 diopter. Optic portions 34 and 37 may be a combination of biconvex, plano-convex, plano-concave, biconcave, concave-convex (meniscus) or a diffractive-type lens element of any shape, depending upon the power required to achieve the appropriate accommodative effects for multi-distance visual imaging and to achieve appropriate central and peripheral thickness for efficient handling and fit within the eye 10. From the perspective of fit within eye 10 and performance, preferably positive lens 33 is convex-plano and negative lens 35 is plano-convex so the piano surface of positive lens 33 is in close proximity to the piano surface of negative lens 35, but most preferably, positive lens 33 is convex-plano and negative lens 35 is concave-plano so the piano surface of positive lens 33 is in close proximity to the concave surface of negative lens 35.
  • [0037] Optic portions 34 and 37 of the subject IOL system 32 may optionally be formed with a glare reduction zone 56 of approximately 0.25 to 2.00 mm but more preferably approximately 0.3 to 0.6 mm and most preferably 0.5 mm in width adjacent outer peripheral edge 36 and 39 for reducing glare when outer peripheral edge 36 and 39 of IOL system 32 is struck by light entering eye 10 during high light or at other times when pupil 58 is dilated. Glare reduction zone 56 is typically fabricated of the same material as optic portions 34 and 37, but may be opaque, colored or patterned in a conventional manner to block or diffuse light in plane with optical axis OA-OA.
  • [0038] Subject IOL system 32 may or may not be of a unitary design and may be molded or most preferably manufactured by first producing disks from a material of choice as described in U.S. Pat. Nos. 5,217,491 and 5,326,506, each incorporated herein in its entirety by reference. If manufactured from disks, positive and negative lenses 33 and 35 respectively, are machined from material disks in a conventional manner. Once machined or molded, positive and negative lenses 33 and 35 may be polished, cleaned, sterilized and packaged by a conventional method known to those skilled in the art.
  • [0039] Subject IOL system 32 is used in eye 10 by creating an incision in cornea 12 and capsule 24, removing natural lens 16, inserting negative lens 35 and positive lens 33 as a unitary device or individually into capsule 24 and closing the incision. Preferably, lenses 35 and 33 are inserted into capsule 24 individually to allow for easier lens folding and smaller incision size. Alternatively, the subject IOL system 32 may be used in eye 10 by creating an incision in cornea 12 and capsule 24, removing natural lens 16, inserting positive lens 33 into capsule 24, inserting negative lens 35 into anterior chamber 20 and closing the incision.
  • [0040] IOL system 32 of the present invention provides for an accommodating lens suitable for use in an aphakic eye 10. IOL system 32 comprises two intraocular lens each having haptic elements 40 and 43 with flexibility characteristics that facilitate opposed axial displacement of optic portions 34 and 37 along optical axis OA-OA of eye 10 thereby enabling an eye to achieve multi-distance visual imaging without the aid of eyeglasses.
  • While there is shown and described herein certain specific embodiments of the present invention, it will be manifest to those skilled in the art that various modifications may be made without departing from the spirit and scope of the underlying inventive concept and that the same is not limited to the particular forms herein shown and described except insofar as indicated by the scope of the appended claims. [0041]

Claims (6)

We claim:
1. An accommodating intraocular lens system to be implanted within an eye generally perpendicular to the eye's optical axis comprising:
a first outer peripheral edge defining a higher diopter positive optic portion with two or more haptic elements permanently connected to the first outer peripheral edge to form a positive lens, wherein said haptic elements each including a contact plate having a trough, and
a second outer peripheral edge defining a lower diopter negative optic portion with two or more haptic elements permanently connected to the second outer peripheral edge to form a negative lens, said haptic elements each including a contact plate having a ridge interlockable with a respective said trough to interlock said positive and negative optic portions together.
2. The intraocular lens system of claim 1 wherein said negative optic portion is axially displaced upon compression.
3. The intraocular lens system of claim 1 wherein said negative lens and said positive lens are both implanted in a lens capsule of an eye.
4. The intraocular lens system of claim 1 wherein said negative lens is implanted in an anterior chamber of an eye and said positive lens is implanted in a lens capsule of an eye.
5. A method of using the intraocular lens system of claim 1 comprising:
creating an incision in a cornea and lens capsule of an eye,
removing a natural lens of said eye, and
inserting a lower diopter negative intraocular lens and a higher diopter positive intraocular lens into said lens capsule of said eye as either individual lenses or as a unitary device.
6. A method of using the intraocular lens system of claim 1 comprising:
creating an incision in a cornea and lens capsule of an eye,
removing a natural lens of said eye,
inserting a lower diopter negative intraocular lens, and
inserting a higher diopter positive intraocular lens into said lens capsule of said eye anterior to said lower diopter negative intraocular lens.
US10/871,935 1999-11-05 2004-06-18 Accommodating positive and negative intraocular lens system Abandoned US20040230300A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/871,935 US20040230300A1 (en) 1999-11-05 2004-06-18 Accommodating positive and negative intraocular lens system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/434,635 US6767363B1 (en) 1999-11-05 1999-11-05 Accommodating positive and negative intraocular lens system
US10/871,935 US20040230300A1 (en) 1999-11-05 2004-06-18 Accommodating positive and negative intraocular lens system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/434,635 Continuation US6767363B1 (en) 1999-11-05 1999-11-05 Accommodating positive and negative intraocular lens system

Publications (1)

Publication Number Publication Date
US20040230300A1 true US20040230300A1 (en) 2004-11-18

Family

ID=23725018

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/434,635 Expired - Lifetime US6767363B1 (en) 1999-11-05 1999-11-05 Accommodating positive and negative intraocular lens system
US10/871,935 Abandoned US20040230300A1 (en) 1999-11-05 2004-06-18 Accommodating positive and negative intraocular lens system

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/434,635 Expired - Lifetime US6767363B1 (en) 1999-11-05 1999-11-05 Accommodating positive and negative intraocular lens system

Country Status (15)

Country Link
US (2) US6767363B1 (en)
EP (1) EP1227773B1 (en)
JP (1) JP2003513705A (en)
CN (2) CN1217632C (en)
AR (1) AR026330A1 (en)
AT (1) ATE384493T1 (en)
AU (1) AU774948B2 (en)
BR (1) BR0015569A (en)
CA (1) CA2389923C (en)
DE (1) DE60037902T2 (en)
ES (1) ES2300278T3 (en)
HK (1) HK1049598B (en)
MX (1) MXPA02004423A (en)
SG (1) SG148832A1 (en)
WO (1) WO2001034067A1 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027354A1 (en) * 2003-07-28 2005-02-03 Advanced Medical Optics, Inc. Primary and supplemental intraocular lens
US20090171458A1 (en) * 2007-12-27 2009-07-02 Kellan Robert E Intraocular lens with accommodation
US20100070030A1 (en) * 2006-11-27 2010-03-18 Michael Amon Intraocular Lens
US20100217387A1 (en) * 2002-12-05 2010-08-26 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US8182531B2 (en) 2006-12-22 2012-05-22 Amo Groningen B.V. Accommodating intraocular lenses and associated systems, frames, and methods
US8343216B2 (en) 2002-01-14 2013-01-01 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US8377125B2 (en) 2006-04-05 2013-02-19 Anew Optics, Inc. Intraocular lens with accommodation
US8425597B2 (en) 1999-04-30 2013-04-23 Abbott Medical Optics Inc. Accommodating intraocular lenses
US8556967B2 (en) 1999-04-09 2013-10-15 Faezeh Mona Sarfarazi Interior bag for a capsular bag and injector
US9011532B2 (en) 2009-06-26 2015-04-21 Abbott Medical Optics Inc. Accommodating intraocular lenses
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
US9439755B2 (en) 2008-11-26 2016-09-13 Anew Iol Technologies, Inc. Haptic devices for intraocular lens
US9486311B2 (en) 2013-02-14 2016-11-08 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US10010405B2 (en) 2008-11-26 2018-07-03 Anew Aol Technologies, Inc. Haptic devices for intraocular lens
US10195018B2 (en) 2013-03-21 2019-02-05 Shifamed Holdings, Llc Accommodating intraocular lens
US10350056B2 (en) 2016-12-23 2019-07-16 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10512535B2 (en) 2016-08-24 2019-12-24 Z Lens, Llc Dual mode accommodative-disaccomodative intraocular lens
US10524900B2 (en) 2010-06-10 2020-01-07 Z Lens, Llc Accommodative intraocular lens and method of improving accommodation
US10548718B2 (en) 2013-03-21 2020-02-04 Shifamed Holdings, Llc Accommodating intraocular lens
US10736734B2 (en) 2014-08-26 2020-08-11 Shifamed Holdings, Llc Accommodating intraocular lens
US10898317B2 (en) 2012-05-10 2021-01-26 Carl Zeiss Meditec Ag Accommodative-disaccommodative intraocular lens
US10987214B2 (en) 2017-05-30 2021-04-27 Shifamed Holdings, Llc Surface treatments for accommodating intraocular lenses and associated methods and devices
US11141263B2 (en) 2015-11-18 2021-10-12 Shifamed Holdings, Llc Multi-piece accommodating intraocular lens
US11266496B2 (en) 2017-06-07 2022-03-08 Shifamed Holdings, Llc Adjustable optical power intraocular lenses
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633110T2 (en) * 1995-02-15 2005-01-05 Medevec Licensing B.V. CUSTOMIZABLE INTRAOCULAR LENS WITH T-SHAPED HOLDERS
US20060149369A1 (en) * 1997-05-20 2006-07-06 C&C Vision International Limited Accommodating arching lens
US7662179B2 (en) 1999-04-09 2010-02-16 Sarfarazi Faezeh M Haptics for accommodative intraocular lens system
WO2002019949A2 (en) * 2000-09-07 2002-03-14 Allergan Sales, Inc. Intraocular lens with a posterior lens portion
US6558420B2 (en) * 2000-12-12 2003-05-06 Bausch & Lomb Incorporated Durable flexible attachment components for accommodating intraocular lens
US20030078657A1 (en) 2001-01-25 2003-04-24 Gholam-Reza Zadno-Azizi Materials for use in accommodating intraocular lens system
US8062361B2 (en) 2001-01-25 2011-11-22 Visiogen, Inc. Accommodating intraocular lens system with aberration-enhanced performance
US6761737B2 (en) 2001-01-25 2004-07-13 Visiogen, Inc. Translation member for intraocular lens system
US20030078658A1 (en) * 2001-01-25 2003-04-24 Gholam-Reza Zadno-Azizi Single-piece accomodating intraocular lens system
US7198640B2 (en) 2001-01-25 2007-04-03 Visiogen, Inc. Accommodating intraocular lens system with separation member
ATE432675T1 (en) * 2001-01-25 2009-06-15 Visiogen Inc ACCOMMODATION INTRAOCULAR LENS SYSTEM
US6884261B2 (en) 2001-01-25 2005-04-26 Visiogen, Inc. Method of preparing an intraocular lens for implantation
US7780729B2 (en) 2004-04-16 2010-08-24 Visiogen, Inc. Intraocular lens
US20120016349A1 (en) 2001-01-29 2012-01-19 Amo Development, Llc. Hybrid ophthalmic interface apparatus and method of interfacing a surgical laser with an eye
FR2831423B1 (en) * 2001-10-31 2004-10-15 Bausch & Lomb INTRAOCULAR LENSES PROVIDED WITH ANGULAR EDGES IN ORDER TO AVOID POSTERIOR CAPSULAR OPACIFICATION
US7097660B2 (en) 2001-12-10 2006-08-29 Valdemar Portney Accommodating intraocular lens
US8048155B2 (en) 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US6695881B2 (en) 2002-04-29 2004-02-24 Alcon, Inc. Accommodative intraocular lens
US20040082993A1 (en) 2002-10-25 2004-04-29 Randall Woods Capsular intraocular lens implant having a refractive liquid therein
US8361145B2 (en) 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US6616691B1 (en) * 2003-01-10 2003-09-09 Alcon, Inc. Accommodative intraocular lens
US7238201B2 (en) 2003-02-13 2007-07-03 Visiogen, Inc. Accommodating intraocular lens system with enhanced range of motion
US7615056B2 (en) 2003-02-14 2009-11-10 Visiogen, Inc. Method and device for compacting an intraocular lens
EP1599748A4 (en) 2003-03-06 2007-10-24 John H Shadduck Adaptive optic lens and method of making
US7223288B2 (en) 2003-05-21 2007-05-29 Alcon, Inc. Accommodative intraocular lens
US7029497B2 (en) 2003-05-21 2006-04-18 Alcon, Inc. Accommodative intraocular lens
US20040249455A1 (en) * 2003-06-09 2004-12-09 Tran Son Trung Accommodative intraocular lens system
US20050125058A1 (en) * 2003-12-03 2005-06-09 Eyeonics, Inc. Accommodating hybrid intraocular lens
US7553327B2 (en) * 2003-12-04 2009-06-30 The Nice Trust, A Trust Of The Isle Of Man Accommodating 360 degree sharp edge optic plate haptic lens
US7645300B2 (en) 2004-02-02 2010-01-12 Visiogen, Inc. Injector for intraocular lens system
US7150760B2 (en) 2004-03-22 2006-12-19 Alcon, Inc. Accommodative intraocular lens system
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US8377123B2 (en) * 2004-11-10 2013-02-19 Visiogen, Inc. Method of implanting an intraocular lens
CA2601351A1 (en) * 2005-03-30 2006-10-05 Nulens Ltd Accommodating intraocular lens (aiol) assemblies, and discrete components therfor
US7771471B2 (en) * 2005-05-13 2010-08-10 C & C Vision International Limited Floating optic accommodating intraocular lens
US7591849B2 (en) 2005-07-01 2009-09-22 Bausch & Lomb Incorpoted Multi-component accommodative intraocular lens with compressible haptic
US8038711B2 (en) * 2005-07-19 2011-10-18 Clarke Gerald P Accommodating intraocular lens and methods of use
EP1924222A1 (en) * 2005-08-05 2008-05-28 Visiogen, Inc. Accommodating diffractive intraocular lens
US7316713B2 (en) 2005-08-29 2008-01-08 Alcon, Inc. Accommodative intraocular lens system
US8034107B2 (en) 2005-09-01 2011-10-11 Stenger Donald C Accommodating intraocular lens
US20070129803A1 (en) * 2005-12-06 2007-06-07 C&C Vision International Limited Accommodative Intraocular Lens
US7981155B2 (en) * 2005-12-07 2011-07-19 C&C Vision International Limited Hydrolic accommodating intraocular lens
US7985253B2 (en) * 2005-12-07 2011-07-26 C&C Vision International Limited Hydrolic accommodating intraocular lens
US20070168027A1 (en) * 2006-01-13 2007-07-19 Brady Daniel G Accommodating diffractive intraocular lens
US20070260308A1 (en) 2006-05-02 2007-11-08 Alcon, Inc. Accommodative intraocular lens system
WO2007138564A1 (en) * 2006-05-31 2007-12-06 Acuity (Israel) Ltd. Accommodating multiple lens assembly
US8163015B2 (en) * 2006-07-25 2012-04-24 C&C Vision International Limited “W” accommodating intraocular lens
US20080154362A1 (en) * 2006-07-25 2008-06-26 C&C Vision International Limited "w" accommodating intraocular lens with elastic hinges
US7763070B2 (en) * 2006-07-25 2010-07-27 C&C Vision International Limited “W” accommodating intraocular lens
US20080027538A1 (en) * 2006-07-27 2008-01-31 Cumming J Stuart Polyspheric Accommodating Intraocular Lens
US8888845B2 (en) * 2006-10-20 2014-11-18 Bausch & Lomb Incorporated Method of inserting an intraocular lens
WO2008079671A1 (en) 2006-12-22 2008-07-03 Bausch & Lomb Incorporated Multi-element accommodative intraocular lens
US7713299B2 (en) 2006-12-29 2010-05-11 Abbott Medical Optics Inc. Haptic for accommodating intraocular lens
CA2674018C (en) 2006-12-29 2015-05-26 Advanced Medical Optics, Inc. Multifocal accommodating intraocular lens
US20080288066A1 (en) * 2007-05-16 2008-11-20 C&C Vision International Limited Toric sulcus lens
KR101494921B1 (en) * 2007-05-29 2015-02-24 스티븐 제이. 델 Accommodative intraocular lens having a haptic plate
US20090228101A1 (en) 2007-07-05 2009-09-10 Visiogen, Inc. Intraocular lens with post-implantation adjustment capabilities
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
US9610155B2 (en) 2008-07-23 2017-04-04 Powervision, Inc. Intraocular lens loading systems and methods of use
US8668734B2 (en) 2010-07-09 2014-03-11 Powervision, Inc. Intraocular lens delivery devices and methods of use
EP2671541B1 (en) 2007-07-23 2019-04-17 PowerVision, Inc. Accommodating intraocular lenses
JP5752415B2 (en) 2007-07-23 2015-07-22 パワーヴィジョン・インコーポレーテッド Correction of the refractive power of the lens after implantation
WO2009064876A1 (en) 2007-11-14 2009-05-22 Alcon, Inc. Accommodative intraocular lens system
US20090198326A1 (en) * 2008-01-31 2009-08-06 Medennium Inc. Accommodative intraocular lens system
JP2012512668A (en) * 2008-11-19 2012-06-07 リフォーカス グループ、インコーポレイテッド Artificial intraocular lens, modified native lens, or refilled native lens capsule with one or more scleral prostheses to improve performance
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
WO2010081093A2 (en) * 2009-01-09 2010-07-15 Powervision, Inc. Intraocular lenses and methods of accounting for capsule size variability and post-implant changes in the eye
GB2468367B (en) * 2009-05-27 2011-02-16 See Again Europ Ltd Intraocular lens systems and methods
GB2476480B (en) 2009-12-22 2013-04-03 Marwan Ghabra Intraocular implant with a fixed and a pivoting lens
US8900298B2 (en) 2010-02-23 2014-12-02 Powervision, Inc. Fluid for accommodating intraocular lenses
JP2013525028A (en) 2010-04-27 2013-06-20 レンスゲン、インコーポレイテッド Adjustable intraocular lens / device
US9351825B2 (en) 2013-12-30 2016-05-31 James Stuart Cumming Semi-flexible posteriorly vaulted acrylic intraocular lens for the treatment of presbyopia
US8523942B2 (en) 2011-05-17 2013-09-03 James Stuart Cumming Variable focus intraocular lens
US9295545B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US9295544B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US9585745B2 (en) 2010-06-21 2017-03-07 James Stuart Cumming Foldable intraocular lens with rigid haptics
US10736732B2 (en) 2010-06-21 2020-08-11 James Stuart Cumming Intraocular lens with longitudinally rigid plate haptic
US9918830B2 (en) 2010-06-21 2018-03-20 James Stuart Cumming Foldable intraocular lens with rigid haptics
US8734512B2 (en) 2011-05-17 2014-05-27 James Stuart Cumming Biased accommodating intraocular lens
US9295546B2 (en) 2013-09-24 2016-03-29 James Stuart Cumming Anterior capsule deflector ridge
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
EP2806828B1 (en) 2012-01-24 2021-07-21 The Regents of The University of Colorado, A Body Corporate Modular intraocular lens designs and methods
US10028824B2 (en) 2012-01-24 2018-07-24 Clarvista Medical, Inc. Modular intraocular lens designs, tools and methods
US9364316B1 (en) 2012-01-24 2016-06-14 Clarvista Medical, Inc. Modular intraocular lens designs, tools and methods
US10080648B2 (en) 2012-01-24 2018-09-25 Clarvista Medical, Inc. Modular intraocular lens designs, tools and methods
US8900300B1 (en) * 2012-02-22 2014-12-02 Omega Ophthalmics Llc Prosthetic capsular bag and method of inserting the same
DE102012106653A1 (en) * 2012-07-23 2014-01-23 Karlsruher Institut für Technologie Wide-angle optics for ophthalmological implants
US10258462B2 (en) 2012-12-26 2019-04-16 Rainbow Medical Ltd. Accommodative intraocular lens
US9925039B2 (en) 2012-12-26 2018-03-27 Rainbow Medical Ltd. Accommodative intraocular lens
BR112015016867A2 (en) 2013-01-15 2017-10-03 Medicem Ophthalmic Cy Ltd [Cy/Cy] BIOANALOGICAL INTRAOCULAR LENS AND ITS IMPLANT
EP2967842B1 (en) 2013-03-15 2020-11-04 Alcon Inc. Method of reconfiguring an intraocular lens for delivery to a delivery device
WO2015066502A1 (en) 2013-11-01 2015-05-07 Thomas Silvestrini Accomodating intraocular lens device
WO2015066532A1 (en) 2013-11-01 2015-05-07 Daniel Brady Two-part accommodating intraocular lens device
US9615916B2 (en) 2013-12-30 2017-04-11 James Stuart Cumming Intraocular lens
ES2948036T3 (en) 2014-02-18 2023-08-30 Alcon Inc Apparatus for resection of an intraocular lens
EP3160404B1 (en) * 2014-06-24 2022-03-16 Rainbow Medical Ltd. Accommodative intraocular lens
US10004596B2 (en) 2014-07-31 2018-06-26 Lensgen, Inc. Accommodating intraocular lens device
US10945832B2 (en) 2014-09-22 2021-03-16 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US10159562B2 (en) 2014-09-22 2018-12-25 Kevin J. Cady Intraocular pseudophakic contact lenses and related systems and methods
US11109957B2 (en) 2014-09-22 2021-09-07 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11938018B2 (en) 2014-09-22 2024-03-26 Onpoint Vision, Inc. Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders
US10299910B2 (en) 2014-09-22 2019-05-28 Kevin J. Cady Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US10647831B2 (en) 2014-09-23 2020-05-12 LensGens, Inc. Polymeric material for accommodating intraocular lenses
US10265163B2 (en) 2014-12-27 2019-04-23 Jitander Dudee Accommodating intraocular lens assembly
AU2015380300B2 (en) 2015-01-30 2020-01-02 Alcon Inc. Modular intraocular lens designs
JP6993328B2 (en) 2015-11-04 2022-01-13 クラービスタ メディカル,インコーポレイテッド Modular intraocular lens system
EP3370647B8 (en) 2015-11-06 2021-06-30 Alcon Inc. Accommodating intraocular lenses and methods of manufacturing
CN113180886A (en) 2015-12-01 2021-07-30 雷恩斯根公司 Accommodating intraocular lens device
US11045309B2 (en) 2016-05-05 2021-06-29 The Regents Of The University Of Colorado Intraocular lens designs for improved stability
EP3463188B1 (en) 2016-05-27 2023-04-26 LensGen, Inc. Lens oil having a narrow molecular weight distribution for intraocular lens devices
US10327886B2 (en) 2016-06-01 2019-06-25 Rainbow Medical Ltd. Accomodative intraocular lens
JP2019520966A (en) 2016-06-23 2019-07-25 メディセム インスティテュート エス.アール.オー. Photo-adjustable hydrogel and bioanalogous intraocular lens
US10441411B2 (en) 2016-12-29 2019-10-15 Rainbow Medical Ltd. Accommodative intraocular lens
US11382736B2 (en) 2017-06-27 2022-07-12 Alcon Inc. Injector, intraocular lens system, and related methods
US10918475B2 (en) * 2017-12-07 2021-02-16 Richard F. Honigsbaum Shrink-wrap anchored and shrink-wrapped actuated accommodative intraocular lenses and methods for implantation thereof
TW201927263A (en) * 2017-12-18 2019-07-16 瑞士商諾華公司 Intraocular lens platform having improved haptic force distribution
WO2021007377A1 (en) * 2019-07-09 2021-01-14 Aaren Scientific Inc. Intraocular lens designs for optimal clinical outcome
EP4041131A4 (en) 2019-10-04 2023-11-15 Alcon Inc. Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses
US11759309B2 (en) 2020-04-29 2023-09-19 Long Bridge Medical, Inc. Devices to support and position an intraocular lens within the eye and methods of use
CN113549174B (en) * 2021-04-06 2023-06-23 上海富吉医疗科技有限公司 Polymer, method for producing polymer, and intraocular lens
US11357620B1 (en) 2021-09-10 2022-06-14 California LASIK & Eye, Inc. Exchangeable optics and therapeutics

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4842601A (en) * 1987-05-18 1989-06-27 Smith S Gregory Accommodating intraocular lens and method of implanting and using same
US4892543A (en) * 1989-02-02 1990-01-09 Turley Dana F Intraocular lens providing accomodation
US5047051A (en) * 1990-04-27 1991-09-10 Cumming J Stuart Intraocular lens with haptic anchor plate
US5217491A (en) * 1990-12-27 1993-06-08 American Cyanamid Company Composite intraocular lens
US5275623A (en) * 1991-11-18 1994-01-04 Faezeh Sarfarazi Elliptical accommodative intraocular lens for small incision surgery
US5326347A (en) * 1991-08-12 1994-07-05 Cumming J Stuart Intraocular implants
US5358520A (en) * 1989-04-28 1994-10-25 Nestle S.A. Supplementary intraocular lens system
US5476514A (en) * 1990-04-27 1995-12-19 Cumming; J. Stuart Accommodating intraocular lens
US5928282A (en) * 1997-06-13 1999-07-27 Bausch & Lomb Surgical, Inc. Intraocular lens
US6096078A (en) * 1997-10-20 2000-08-01 Surgical Concepts, Inc. Accommodative lens implantation
US6488708B2 (en) * 1999-04-09 2002-12-03 Faezeh Sarfarazi Open chamber, elliptical, accommodative intraocular lens system
US20030060881A1 (en) * 1999-04-30 2003-03-27 Advanced Medical Optics, Inc. Intraocular lens combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569557A1 (en) * 1984-08-31 1986-03-07 Siepser Steven B Improved artificial intraocular lenses
US4888012A (en) 1988-01-14 1989-12-19 Gerald Horn Intraocular lens assemblies
CS271606B1 (en) 1988-04-11 1990-10-12 Sulc Jiri Intraocular optical system
JP2718961B2 (en) * 1988-11-04 1998-02-25 株式会社メニコン Intraocular lens
FR2666220B1 (en) 1990-09-04 1996-03-01 Domilens Lab INTRAOCULAR IMPLANT FOR CORRECTION OF MYOPIA.
US5354335A (en) 1993-02-04 1994-10-11 Isaac Lipshitz Intraocular insert for implantation in the human eye
DE19501444A1 (en) * 1995-01-19 1996-07-25 Morcher Gmbh Intra ocular two lens system
JP2001520077A (en) 1997-10-22 2001-10-30 ソシエテ・メデイカル・ドウ・プレシジヨン・エス・エム・ペー・エス・アー Intraocular lens device
US6616692B1 (en) 1999-04-30 2003-09-09 Advanced Medical Optics, Inc. Intraocular lens combinations

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4842601A (en) * 1987-05-18 1989-06-27 Smith S Gregory Accommodating intraocular lens and method of implanting and using same
US4892543A (en) * 1989-02-02 1990-01-09 Turley Dana F Intraocular lens providing accomodation
US5358520A (en) * 1989-04-28 1994-10-25 Nestle S.A. Supplementary intraocular lens system
US5047051A (en) * 1990-04-27 1991-09-10 Cumming J Stuart Intraocular lens with haptic anchor plate
US5674282A (en) * 1990-04-27 1997-10-07 Cumming; J. Stuart Accommodating intraocular lens
US5496366A (en) * 1990-04-27 1996-03-05 Cumming; J. Stuart Accommodating intraocular lens
US5476514A (en) * 1990-04-27 1995-12-19 Cumming; J. Stuart Accommodating intraocular lens
US5217491A (en) * 1990-12-27 1993-06-08 American Cyanamid Company Composite intraocular lens
US5326506A (en) * 1990-12-27 1994-07-05 American Cyanamid Company Method for making a composite intraocular lens
US5326347A (en) * 1991-08-12 1994-07-05 Cumming J Stuart Intraocular implants
US5275623A (en) * 1991-11-18 1994-01-04 Faezeh Sarfarazi Elliptical accommodative intraocular lens for small incision surgery
US5928282A (en) * 1997-06-13 1999-07-27 Bausch & Lomb Surgical, Inc. Intraocular lens
US6096078A (en) * 1997-10-20 2000-08-01 Surgical Concepts, Inc. Accommodative lens implantation
US6488708B2 (en) * 1999-04-09 2002-12-03 Faezeh Sarfarazi Open chamber, elliptical, accommodative intraocular lens system
US20030060881A1 (en) * 1999-04-30 2003-03-27 Advanced Medical Optics, Inc. Intraocular lens combinations

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8556967B2 (en) 1999-04-09 2013-10-15 Faezeh Mona Sarfarazi Interior bag for a capsular bag and injector
US9149356B2 (en) 1999-04-09 2015-10-06 Faezeh Mona Sarfarazi Interior bag for a capsular bag and injector
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US8425597B2 (en) 1999-04-30 2013-04-23 Abbott Medical Optics Inc. Accommodating intraocular lenses
US8343216B2 (en) 2002-01-14 2013-01-01 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US9504560B2 (en) 2002-01-14 2016-11-29 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US10206773B2 (en) 2002-12-05 2019-02-19 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lens and method of manufacture thereof
US20100217387A1 (en) * 2002-12-05 2010-08-26 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US9271830B2 (en) * 2002-12-05 2016-03-01 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US20050027354A1 (en) * 2003-07-28 2005-02-03 Advanced Medical Optics, Inc. Primary and supplemental intraocular lens
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US8377125B2 (en) 2006-04-05 2013-02-19 Anew Optics, Inc. Intraocular lens with accommodation
US10004592B2 (en) * 2006-11-27 2018-06-26 Rayner Intraocular Lenses Limited Intraocular lens
US20100070030A1 (en) * 2006-11-27 2010-03-18 Michael Amon Intraocular Lens
US8496701B2 (en) 2006-12-22 2013-07-30 Amo Groningen B.V. Accommodating intraocular lenses and associated systems, frames, and methods
US8182531B2 (en) 2006-12-22 2012-05-22 Amo Groningen B.V. Accommodating intraocular lenses and associated systems, frames, and methods
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
US20140005782A1 (en) * 2007-12-27 2014-01-02 Anew Optics, Inc. Intraocular Lens with Accommodation
US8480734B2 (en) * 2007-12-27 2013-07-09 Anew Optics, Inc. Intraocular lens with accommodation
US20090171458A1 (en) * 2007-12-27 2009-07-02 Kellan Robert E Intraocular lens with accommodation
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US9439755B2 (en) 2008-11-26 2016-09-13 Anew Iol Technologies, Inc. Haptic devices for intraocular lens
US10010405B2 (en) 2008-11-26 2018-07-03 Anew Aol Technologies, Inc. Haptic devices for intraocular lens
US9011532B2 (en) 2009-06-26 2015-04-21 Abbott Medical Optics Inc. Accommodating intraocular lenses
US10052194B2 (en) 2009-06-26 2018-08-21 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lenses
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US10105215B2 (en) 2009-08-03 2018-10-23 Johnson & Johnson Surgical Vision, Inc. Intraocular lens and methods for providing accommodative vision
US10524900B2 (en) 2010-06-10 2020-01-07 Z Lens, Llc Accommodative intraocular lens and method of improving accommodation
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US10898317B2 (en) 2012-05-10 2021-01-26 Carl Zeiss Meditec Ag Accommodative-disaccommodative intraocular lens
US10350057B2 (en) 2013-02-14 2019-07-16 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US10709549B2 (en) 2013-02-14 2020-07-14 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US11540916B2 (en) 2013-02-14 2023-01-03 Shifamed Holdings, Llc Accommodating intraocular lens
US9486311B2 (en) 2013-02-14 2016-11-08 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US10195018B2 (en) 2013-03-21 2019-02-05 Shifamed Holdings, Llc Accommodating intraocular lens
US10548718B2 (en) 2013-03-21 2020-02-04 Shifamed Holdings, Llc Accommodating intraocular lens
US10736734B2 (en) 2014-08-26 2020-08-11 Shifamed Holdings, Llc Accommodating intraocular lens
US11583390B2 (en) 2014-08-26 2023-02-21 Shifamed Holdings, Llc Accommodating intraocular lens
US11141263B2 (en) 2015-11-18 2021-10-12 Shifamed Holdings, Llc Multi-piece accommodating intraocular lens
US10512535B2 (en) 2016-08-24 2019-12-24 Z Lens, Llc Dual mode accommodative-disaccomodative intraocular lens
US10350056B2 (en) 2016-12-23 2019-07-16 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US11065109B2 (en) 2016-12-23 2021-07-20 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10987214B2 (en) 2017-05-30 2021-04-27 Shifamed Holdings, Llc Surface treatments for accommodating intraocular lenses and associated methods and devices
US11266496B2 (en) 2017-06-07 2022-03-08 Shifamed Holdings, Llc Adjustable optical power intraocular lenses
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Also Published As

Publication number Publication date
EP1227773B1 (en) 2008-01-23
EP1227773A1 (en) 2002-08-07
SG148832A1 (en) 2009-01-29
JP2003513705A (en) 2003-04-15
DE60037902D1 (en) 2008-03-13
DE60037902T2 (en) 2009-01-29
CA2389923C (en) 2006-01-24
US6767363B1 (en) 2004-07-27
MXPA02004423A (en) 2002-09-02
ES2300278T3 (en) 2008-06-16
CN1384727A (en) 2002-12-11
BR0015569A (en) 2002-07-30
CA2389923A1 (en) 2001-05-17
WO2001034067A1 (en) 2001-05-17
ATE384493T1 (en) 2008-02-15
AU774948B2 (en) 2004-07-15
AU1229301A (en) 2001-06-06
CN1720877A (en) 2006-01-18
HK1049598A1 (en) 2003-05-23
CN1217632C (en) 2005-09-07
AR026330A1 (en) 2003-02-05
HK1049598B (en) 2008-06-27

Similar Documents

Publication Publication Date Title
US6767363B1 (en) Accommodating positive and negative intraocular lens system
US6685741B2 (en) Intraocular lenses
US6558420B2 (en) Durable flexible attachment components for accommodating intraocular lens
US6190410B1 (en) Intraocular lenses
US6461384B1 (en) Intraocular lenses
US6200344B1 (en) Inraocular lenses
AU1320800A (en) Flexible intraocular lens
AU6945100A (en) Intraocular lenses
AU2004229073B2 (en) Intraocular lenses

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: MERGER;ASSIGNOR:BAUSCH & LOMB SURGICAL, INC.;REEL/FRAME:014796/0416

Effective date: 20010329

AS Assignment

Owner name: CREDIT SUISSE, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:BAUSCH & LOMB INCORPORATED;B&L CRL INC.;B&L CRL PARTNERS L.P.;AND OTHERS;REEL/FRAME:020122/0722

Effective date: 20071026

Owner name: CREDIT SUISSE,NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:BAUSCH & LOMB INCORPORATED;B&L CRL INC.;B&L CRL PARTNERS L.P.;AND OTHERS;REEL/FRAME:020122/0722

Effective date: 20071026

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH;REEL/FRAME:028726/0142

Effective date: 20120518